Potent knock down of HIV-1 replication by targeting HIV-1 Tat/Rev RNA sequences synergistically with catalytic RNA and DNA

AIDS

Volumn 21, Issue 1, 2007, Pages 31-40

  Sood, Vikas ^a   Unwalla, Hoshang ^a   Gupta, Nidhi ^a   Chakraborti, Samitabh ^a   Banerjea, Akhil C ^a  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

Author keywords

DNA enzymes; HIV; Rev; Ribozymes; Tat

Indexed keywords

DEOXYRIBOZYME; HAMMERHEAD RIBOZYME; REV PROTEIN; RIBOZYME; TRANSACTIVATOR PROTEIN;

ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DNA CLEAVAGE; DOSE RESPONSE; DRUG DESIGN; DRUG EFFECT; DRUG POTENTIATION; EXON; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN MOTIF; PROTEIN TARGETING; RNA CLEAVAGE; RNA SEQUENCE; VIRUS INHIBITION; VIRUS REPLICATION;

AMINO ACID SEQUENCE; BASE SEQUENCE; CLONING, MOLECULAR; DNA, CATALYTIC; GENE EXPRESSION REGULATION; GENE TARGETING; GENE THERAPY; GENES, REV; GENES, TAT; GENETIC ENGINEERING; HIV-1; HUMANS; MACROPHAGES; MOLECULAR SEQUENCE DATA; READING FRAMES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, CATALYTIC; VIRUS REPLICATION;

EID: 33845494065     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3280118fb6     Document Type: Article

References (33)

1. Joyce GF. Directed evolution of nucleic acid enzymes. Annu Rev Biochem 2004; 73:791-836.
2. Puerta-Fernandez E, Barroso-del Jesus A, Romero-Lopez C, Tapia N, Martinez MA, Berzal-Herranz A. Inhibition of HIV-1 replication by RNA targeted against the LTR region. AIDS 2005; 19:863-870.
3. Rossi JJ. The application of ribozymes to HIV infection. Curr Opin Mol Ther 1999; 1:316-322.
4. Santoro SW, Joyce GF. A general purpose RNA-cleaving DNA enzyme. Proc Natl Acad Sci USA 1997; 94:4262-4266.
5. Banerjea AC, Ming-Jie L, Bauer G, Remling L, Lee NS, Rossi J, Akkina R. Inhibition of HIV-1 by lentiviral vector-transduced siRNAs in T lymphocytes differentiated in SCID-hu mice and CD34+ progenitor cell-derived macrophages. Mol Ther 2003; 8:62-71.
6. Banerjea A, Ming-Ji Li, Remling L, Rossi J, Akkina R. Lentiviral transduction of Tar Decoy and CCR5 ribzozyme into CD34+ progenitor cells and derivation of HIV-1 resistant T cells and macrophages. AIDS Res Ther 2004; 17th December 2004, (Biomed central).
7. Schubert S, Furste JP, Werk D, Grunert HP, Zeichhardt H, Erdmann VA, Kurreck J. Gaining target access for deoxyribozymes. J Mol Biol 2004; 339:355-363.
8. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001; 411:494-498.
9. Holen T, Amarzguioui M, Wigger MT, Babaie E, Prydz H. Positional effects of short interfering RNAs targeting the human coagulation trigger tissue factor. Nucleic Acids Res 2002; 30:1757-1766.
10. Lee NS, Taikoh D, Bauer G, Li H, Li MJ, Ehsani A, et al. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat Biotechnol 2002; 20:500-505.
11. Yu JY, DeRuiter SL, Turner DL. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc Natl Acad Sci USA 2002; 99:6047-6052.
12. Castanotto D, Li H, Rossi JJ. Functional siRNA expression from transfected PCR products. RNA 2002; 8:1454-1460.
13. Unwalla H, Banerjea AC. Novel mono- and Di-DNA-enzymes targeted to cleave TAT or TAT-Rev RNA inhibit HIV-1 gene expression. Antiviral Res 2001; 51:127-139.
14. Unwalla H, Banerjea AC. Inhibition of HIV-1 gene expression by novel macrophage-tropic -DNA-enzymes targeted to cleave HIV-1 TAT/Rev RNA. Biochem J 2001; 357:97-105.
15. Dash BC, Banerjea AC. Sequence specific cleavage activities of DNA-enzymes targeted against HIV-1 Gag and Nef regions. Oligonucleotides 2004; 14:41-47.
16. Scherr M, Rossi JJ. Rapid determination and quantitation of the accessibility to native RNAs by antisense oligodeoxynucleotides in murine cell extracts. Nucleic Acids Res 1998; 26:5079-5085.
17. Goila R, Banerjea AC. Sequence-specific cleavage of HIV-1 coreceptor-CCR5 gene by a hammerhead ribozyme and a DNA-enzyme: Inhibition of the coreceptor function by DNA-enzyme. FEBS Letters 1998; 436:233-238.
18. Ackermann JM, Kanugula S, Pegg AE. DNAzyme-mediated silencing of ornithine decarboxylase. Biochemistry 2005; 44:2143-2152.
19. Kurreck J, Bieber B, Jahnel R, Erdmann VA. Comparative study of DNA enzymes and ribozymes against the same full-length messenger RNA of the Vanilloid receptor subtype 1. J Biol Chem 2002; 277:7099-7107.
20. Fitzgerald ML, Moore KJ, Freeman NW, Reed GL. Lipopolysaccharide induces scavenger receptor A expression in mouse macrophages: A divergent response relative to human THP-1 monocyte/macrophages. J Immunol 2000; 164:2692-2700.
21. Adachi A, Glendelman HE, Koenig S, Folks T, Willey R, Rabsom A, Martin M. Production of acquired immunodeficiency syndrome associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol 1986; 59:284-291.
22. Goila R, Banerjea AC. Inhibition of hepatitis B virus X gene expression by novel DNAenzymes. Biochemical J 2001; 353:701-708.
23. Banerjea AC, Joklik WK. Reovirus protein sigma 1 translated in vitro as well as truncated derivatives of it that lack up to two-thirds of its C-terminal portion, exists as two major tetrameric molecular species that differ in electrophoretic mobility. Virology 1990; 179:460-462.
24. Shahi S, Shanmugasundaram GK, Banerjea AC. Ribozymes that cleave reovirus genome segments S1 also protect cells from pathogenesis caused by reovirus infection. Proc Natl Acad Sci USA 2001; 98:4101-4106.
25. Dash BP, Harikrishnan TA, Goila R, Shahi S, Unwalla H, Husain S, Banerjea AC. Targeted cleavage of HIV-1 envelope gene by a DNA-enzyme and inhibition of HIV-1 envelope-CD4 mediated cell fusion. FEBS Letters 1998; 431:395-399.
26. Basu S, Sriram B, Goila R, Banerjea AC. Targeted cleavage of HIV-1 coreceptor-CXCR4 by RNA cleaving DNA-enzyme: Inhibition of coreceptor function. Antiviral Res 2000; 46:125-134.
27. Paik SY, Banerjea A, Chen CJ, Ye J, Harmison GG, Schubert M. Defective HIV-1 provirus encoding a multitarget-ribozyme inhibits accumulation of spliced and unspliced HIV-1 mRNAs, reduces infectivity of viral progeny and protects the cells from pathogenesis. Hum Gene Ther 1997; 8:1115-1124.
28. Li MJ, Bauer G, Michienzi A, Yee JK, Lee NS, Kim J, et al. Inhibition of HIV-1 infection by lentiviral vectors expressing Pol III-promoted anti-HIV- RNAs. Mol Ther 2003; 8:196-206.
29. Weinberg MS, Rossi JJ. Comparative single-turnover kinetic analyses of trans-cleaving hammerhead ribozymes with naturally derived non-conserved sequence motifs. FEBS Letters 2005; 579:1619-1624.
30. Banerjea AC, Chakraborti S, Unwalla H, Goila R, Shrbani S, Dash BC, et al. Potential therapeutic application of DNA enzymes and siRNAs against viral and cellular genes. In: Synthetic nucleic acids as inhibitors of gene expression: mechanisms, applications, and therapeutic implications. Edited by Khachigian LM. Boca Raton, Florida: CRC Press; 2004. pp. 115-134.
31. Kusunoki A, Miyano-Kurosaki N, Takaku H. A novel single-stranded DNA enzyme expression system using HIV-1 reverse transcriptase. Biochem Biophys Res Comm 2003; 301:535-538.
32. Chen Y, McMicken HW. Intracellular production of DNA-enzyme by a novel single-stranded DNA expression vector. Gene Therapy 2003; 10:1776-1784.
33. Ye Z, Harmison GG, Ragheb JA, Schubert M. Targeted infection of HIV-1 Env expressing cells by HIV (CD4/CXCR4) vectors reveals a potential new rationale for HIV-1 mediated down-modulation of CD4. Retrovirology 2005; 2:80; 21st December (BioMed Central).